Nick’s practice is based in the broad field of biosciences, with significant clients in the areas of biotechnology and medical devices. His expertise lies in immunology (in particular, antibodies/T cells), RNA interference, nanotechnology, recombinant DNA technology, diagnostics and microparticle technology.
His time is primarily focused on prosecution and opposition matters at the European Patent Office. His experience and success in these areas mean that he is often asked to deal with cutting edge and high profile cases. For example, he represented The Johns Hopkins University in the seminal case that set the 'plausibility' test for the amount of data required to support inventive step in a European patent (T1329/04).
Nick’s large and ever-growing client base spans UK companies, overseas attorneys and large multinationals. His passions include working with biotechnology companies, adding value by building strong and customised patent portfolios, designing and implementing patenting strategies and providing commercial and strategic advice on third party rights in due diligence exercises. He also provides advice directly to a number of US companies in the biosciences area, who highly value his expertise and ability to obtain and protect their European IP.
Outside his casework, Nick is closely involved with the smooth running of the firm and his skills extend to responsibility for the management of many of Kilburn & Strode’s departments.
Year Joined Firm: c. 1999
Education/Alumni: University of Bristol
Network Memberships: CIPA, EPI
Last updated 25 October 2021
